This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cataract
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Femtosecond laser-assisted cataract surgery consists in nuclear lens fragmentation, followed by ultrasound phacoemulsification of nuclear lens, which is then removed. It can be assumed that fragmenting the nuclear lens in more pieces could facilitate the post-laser ultrasound phacoemulsification to extract the lens, with a lesser amount of ultrasonic energy. The decrease of ultrasonic energy delivered during cataract surgery is beneficial to the patient because it optimizes the vitality of corneal endothelial cells, which ensure corneal transparency.

Provided treatments

  • Device: nuclear lens fragmentation in 8 pieces
  • Device: nuclear lens fragmentation in 16 pieces

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02898909. The sponsor of the trial is Fondation Ophtalmologique Adolphe de Rothschild and it is looking for 5 volunteers for the current phase.
Official trial title: